The Role of Mir-148a in Cancer

被引:123
|
作者
Li, Yue [1 ]
Deng, Xiyun [1 ]
Zeng, Xiaomin [2 ]
Peng, Xiaoning [1 ]
机构
[1] Hunan Normal Univ, Sch Med, Dept Pathol & Pathophysiol, Changsha 410013, Hunan, Peoples R China
[2] Cent S Univ, Sch Publ Hlth, Dept Stat & Epidemiol, Changsha 410078, Hunan, Peoples R China
来源
JOURNAL OF CANCER | 2016年 / 7卷 / 10期
基金
中国国家自然科学基金;
关键词
miRNA; mir-148a; cancer; oncogene; tumor suppressor gene; biological function; CELL LUNG-CANCER; EPITHELIAL-MESENCHYMAL TRANSITION; DNA METHYLTRANSFERASE 1; GASTRIC-CANCER; MICRORNA-148A SUPPRESSES; HEPATOCELLULAR-CARCINOMA; BREAST-CANCER; CLINICAL-SIGNIFICANCE; COLORECTAL-CANCER; SIGNALING PATHWAY;
D O I
10.7150/jca.14616
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
MicroRNAs (miRNAs) are highly conserved noncoding RNAs of about 19-25 nucleotides. Through specifically pairing with complementary sites in 3' untranslated regions (UTRs) of target mRNAs, they mediate post-transcriptional silencing. MicroRNAs have been implicated in many physiological processes including proliferation, differentiation, development, apoptosis, and metabolism. In recent years many studies have revealed that the aberrant expression of miRNA is closely related to oncogenesis and is now an intense field of study. Mir-148a is aberrantly expressed in various cancers and has been identified as an oncogenic or tumor suppressor with crucial roles in the molecular mechanisms of oncogenesis. In this review, we have summarized the role of mir-148a in the oncogenic pathways of gastric, liver, breast and urogenital cancers, and in neurogliocytoma oncogenesis. Studying the functional role of mir-148a is crucial in discovering novel tumor molecular markers and identifying potential therapeutic targets.
引用
收藏
页码:1233 / 1241
页数:9
相关论文
共 50 条
  • [21] miR-148a controls plasma cell differentiation and survival
    Pracht, K.
    Meinzinger, J.
    Daum, P.
    Corte-Real, J.
    Hauke, M.
    Schulz, S.
    Wittmann, J.
    Jaeck, H. M.
    [J]. EUROPEAN JOURNAL OF IMMUNOLOGY, 2017, 47 : 46 - 46
  • [22] Inhibition of miR-148a results in accelerated dilated cardiomyopathy
    Philippen, L. E.
    Dirkx, E.
    Lopez-Andres, N.
    Bitsch, N.
    Martins, P. A. Da Costa
    De Windt, L. J.
    [J]. EUROPEAN JOURNAL OF HEART FAILURE, 2013, 12 : S55 - S55
  • [23] MIR-148A REGULATES CHIEF CELL PLASTICITY IN THE STOMACH
    Sohn, Yoojin
    Shimizu, Takahiro
    Choi, Eunyoung
    Goldenring, James R.
    [J]. GASTROENTEROLOGY, 2019, 156 (06) : S212 - S212
  • [24] miR-148a controls plasma cell differentiation and survival
    Pracht, Katharina
    Meinzinger, Julia
    Daum, Patrick
    Corte-Real, Joana
    Hauke, Manuela
    Schulz, Sebastian
    Roth, Edith
    Wittmann, Jurgen
    Jack, Hans-Martin
    [J]. JOURNAL OF IMMUNOLOGY, 2017, 198 (01):
  • [25] Hypoxia-Induced miR-148a Downregulation Contributes to Poor Survival in Colorectal Cancer
    Nersisyan, Stepan
    Galatenko, Alexei
    Chekova, Milena
    Tonevitsky, Alexander
    [J]. FRONTIERS IN GENETICS, 2021, 12
  • [26] Prognostic value of expression levels of miR-148a, miR-152 and HLA-G in colon cancer
    Emirzeoglu, Levent
    Olmez, Ozgur
    Mustafayev, Fatma Nihan Akkoc
    Berber, Ufuk
    Yilmaz, Ismail
    Celik, Serkan
    Oven, Bala Basak
    Ozgun, Mehmet Alpaslan
    [J]. ONCOLOGY LETTERS, 2022, 24 (01)
  • [27] Serum miR-152, miR-148a, miR-148b, and miR-21 as novel biomarkers in non-small cell lung cancer screening
    Yang, Jin-shan
    Li, Bao-jian
    Lu, Hua-wei
    Chen, Yu
    Lu, Chuan
    Zhu, Rui-xia
    Liu, Si-hai
    Yi, Qing-ting
    Li, Jing
    Song, Chun-hui
    [J]. TUMOR BIOLOGY, 2015, 36 (04) : 3035 - 3042
  • [28] MiR-148a inhibits angiogenesis by targeting ERBB3
    Yu, Jing
    Li, Qi
    Xu, Qing
    Liu, Lingzhi
    Jiang, Binghua
    [J]. JOURNAL OF BIOMEDICAL RESEARCH, 2011, 25 (03): : 170 - 177
  • [29] MiR-148a inhibits angiogenesis by targeting ERBB3
    Jing Yua
    bDepartment of Pathology
    [J]. The Journal of Biomedical Research, 2011, (03) : 170 - 177
  • [30] The Janus Face of miR-148a in Cardiac Remodeling and Heart Failure
    Hobuss, Lisa
    Thum, Thomas
    [J]. MOLECULAR THERAPY, 2019, 27 (03) : 489 - 490